Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus Infections
23 avr. 2020 03h00 HE | Cytovance Biologics
OKLAHOMA CITY, April 23, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a USA-based contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink...